Shinhung Co., Ltd (KRX:004080)
14,600
0.00 (0.00%)
At close: Jun 5, 2025, 3:30 PM KST
Shinhung Revenue
Shinhung had revenue of 23.62B KRW in the quarter ending March 31, 2025, a decrease of -10.04%. This brings the company's revenue in the last twelve months to 99.12B, down -9.91% year-over-year. In the year 2024, Shinhung had annual revenue of 101.76B, down -9.50%.
Revenue (ttm)
99.12B
Revenue Growth
-9.91%
P/S Ratio
1.39
Revenue / Employee
495.60M
Employees
200
Market Cap
137.95B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 101.76B | -10.69B | -9.50% |
Dec 31, 2023 | 112.44B | -5.73B | -4.85% |
Dec 31, 2022 | 118.18B | -8.68B | -6.84% |
Dec 31, 2021 | 126.85B | 10.20B | 8.74% |
Dec 31, 2020 | 116.65B | -6.36B | -5.17% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,898.69B |
Celltrion | 3,662.23B |
ALTEOGEN | 151.65B |
Yuhan | 2,114.76B |
SK Biopharmaceuticals | 578.00B |
HLB Co., Ltd. | 74.64B |
PharmaResearch | 392.31B |
LigaChem Biosciences | 146.42B |